Roche Holding AG
SIX:RO

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:RO
Watchlist
Price: 353.4 CHF 1.55% Market Closed
Market Cap: 244B CHF

Relative Value

The Relative Value of one RO stock under the Base Case scenario is hidden CHF. Compared to the current market price of 353.4 CHF, Roche Holding AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
30
Median 3Y
3.5
Median 5Y
3.8
Industry
2.7
Forward
4.4
vs History
0
vs Industry
22
Median 3Y
19.6
Median 5Y
19
Industry
21.6
Forward
17.2
vs History
7
vs Industry
28
Median 3Y
11.8
Median 5Y
12.4
Industry
16.9
vs History
25
vs Industry
19
Median 3Y
15.5
Median 5Y
15.6
Industry
22.9
vs History
17
vs Industry
7
Median 3Y
7.3
Median 5Y
7.5
Industry
2.3
vs History
4
vs Industry
27
Median 3Y
3.8
Median 5Y
4
Industry
3
Forward
4.8
vs History
15
vs Industry
34
Median 3Y
5.1
Median 5Y
5.5
Industry
5.6
vs History
14
vs Industry
29
Median 3Y
9.8
Median 5Y
10.3
Industry
13.4
Forward
12.2
vs History
17
vs Industry
30
Median 3Y
11.7
Median 5Y
12.3
Industry
16.7
Forward
14.2
vs History
1
vs Industry
27
Median 3Y
12.7
Median 5Y
13
Industry
16.1
vs History
0
vs Industry
10
Median 3Y
17.7
Median 5Y
18
Industry
18.9
vs History
26
vs Industry
22
Median 3Y
2.9
Median 5Y
3.2
Industry
2

Multiples Across Competitors

RO Competitors Multiples
Roche Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Roche Holding AG
SIX:RO
276.2B CHF 4.5 29.3 12.4 14.5
US
Eli Lilly and Co
NYSE:LLY
966.6B USD 16.3 52.5 35.3 37.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
523.5B USD 5.7 20.8 17 22.1
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP 5.1 31.5 109.1 159.6
CH
Novartis AG
SIX:NOVN
222.2B CHF 5 19.3 12.2 15.8
US
Merck & Co Inc
NYSE:MRK
273.4B USD 4.3 14.4 10.2 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.7B USD 2.3 14.7 7.5 10.2
FR
Sanofi SA
PAR:SAN
99.3B EUR 1.5 7.2 6.6 6.6
P/E Multiple
Earnings Growth PEG
CH
Roche Holding AG
SIX:RO
Average P/E: 22.8
29.3
29%
1
US
Eli Lilly and Co
NYSE:LLY
52.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.8
29%
0.7
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
CH
Novartis AG
SIX:NOVN
19.3
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
FR
Sanofi SA
PAR:SAN
7.2
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Roche Holding AG
SIX:RO
Average EV/EBITDA: 400.6
12.4
5%
2.5
US
Eli Lilly and Co
NYSE:LLY
35.3
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17
9%
1.9
UK
AstraZeneca PLC
LSE:AZN
109.1
10%
10.9
CH
Novartis AG
SIX:NOVN
12.2
6%
2
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
FR
Sanofi SA
PAR:SAN
6.6
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Roche Holding AG
SIX:RO
Average EV/EBIT: 1 713
14.5
6%
2.4
US
Eli Lilly and Co
NYSE:LLY
37.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.1
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
159.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.8
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5
FR
Sanofi SA
PAR:SAN
6.6
15%
0.4